Drugs giant GSK is set to move its global headquarters back to central London, ending more than two decades at its Brentford base. Around 3,000 employees will work from The Earnshaw building on ...

GSK has selected a site currently being constructed ... which is currently located to the west of the capital in Brentford and put up for sale last year. The company said in a statement that ...

GSK has continued to beat my expectations as ... First, on August 1, the Brentford-based company announced that the FDA had approved Jemperli in combination with two chemotherapy medicines ...

The 21-year-old company employs more than 450 people, 150 of whom work at the Durham manufacturing site. GSK, headquartered in Brentford, UK, is a global healthcare company with around 100,000 ...

Energy is the physical or mental ability that allows an individual to do something. GlaxoSmithKline (GSK), headquartered in Brentford, London and one of the largest healthcare companies in the world ...

Physicians should track clinical remission in patients with asthma on biologics and monitor for EGPA symptoms, as ...

Berenberg Bank analyst Kerry Holford maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a price target ...

GSK-3739937 is commercialized by GSK, with a leading Phase I program in Human Immunodeficiency Virus (HIV) Infections (AIDS).

Several drugs, such as gefitinib and erlotinib, are specific for EGFR, whereas others (lapatinib [GlaxoSmithKline, Brentford, UK], vandetanib [AstraZeneca, London, UK], and AEE788 [Novartis ...

GlobalData uses proprietary data and analytics to provide a complete picture of GSK -3943104A’s valuation in its risk-adjusted NPV model (rNPV). Buy the model here. The revenue for GSK -3943104A is ...